These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28421628)

  • 21. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
    Rudnick MR; Davidson C; Laskey W; Stafford JL; Sherwin PF;
    Am Heart J; 2008 Oct; 156(4):776-82. PubMed ID: 18946896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
    Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
    Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
    Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
    Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy.
    Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Lundkvist J
    Am Heart J; 2005 Feb; 149(2):298-303. PubMed ID: 15846268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
    Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
    J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study.
    From AM; Bartholmai BJ; Williams AW; McDonald FS
    Acta Radiol; 2008 May; 49(4):409-14. PubMed ID: 18415784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.
    Jo SH; Koo BK; Park JS; Kang HJ; Cho YS; Kim YJ; Youn TJ; Chung WY; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
    Am Heart J; 2008 Mar; 155(3):499.e1-8. PubMed ID: 18294484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
    Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
    AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy.
    Adolph E; Holdt-Lehmann B; Chatterjee T; Paschka S; Prott A; Schneider H; Koerber T; Ince H; Steiner M; Schuff-Werner P; Nienaber CA
    Coron Artery Dis; 2008 Sep; 19(6):413-9. PubMed ID: 18955835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
    From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS
    Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.
    Jabara R; Gadesam RR; Pendyala LK; Knopf WD; Chronos N; Chen JP; Viel K; King SB; Manoukian SV
    Am J Cardiol; 2009 Jun; 103(12):1657-62. PubMed ID: 19539072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Corin Level Is Associated With Subsequent Decline in Renal Function in Patients With Suspected Coronary Artery Disease.
    Yang SF; Chou RH; Li SY; Huang SS; Huang PH
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention.
    Jakobsen JA; Berg KJ; Kjaersgaard P; Kolmannskog F; Nordal KP; Nossen JO; Rootwelt K
    Nephron; 1996; 73(4):549-56. PubMed ID: 8856250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary computed tomographic angiography in coronary artery bypass grafts: comparison between low-concentration Iodixanol 270 and Iohexol 350.
    Wang H; Xu L; Zhang N; Fan Z; Zhang Z; Sun Z
    J Comput Assist Tomogr; 2015; 39(1):112-8. PubMed ID: 25299799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iodixanol versus Iopromide at Coronary CT Angiography: Lumen Opacification and Effect on Heart Rhythm-the Randomized IsoCOR Trial.
    Lubbers MM; Kock M; Niezen A; Galema T; Kofflard M; Bruning T; Kooij HS; van Valen H; Dijkshoorn M; Booij R; Padmos A; Vogels A; Budde RPJ; Nieman K
    Radiology; 2018 Jan; 286(1):71-80. PubMed ID: 28809582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial.
    Brar SS; Shen AY; Jorgensen MB; Kotlewski A; Aharonian VJ; Desai N; Ree M; Shah AI; Burchette RJ
    JAMA; 2008 Sep; 300(9):1038-46. PubMed ID: 18768415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.
    Ladwig M; Flemming B; Seeliger E; Sargsyan L; Persson PB
    Invest Radiol; 2011 Nov; 46(11):672-7. PubMed ID: 21623210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
    Schönefeld E; Höwler S; Osada N; Torsello G
    Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.